A Bittersweet Wait: Immuron's Travelan Data Faces an Unexpected Delay

Biotech's Pulse Check: AI Rises, a Cancer Test Stumbles, and a Rare Disease Shines

The Unseen Surge: What Sent Profusa Stock Skyrocketing After Hours?

The Biotech Beat: Unpacking a Week of Breakthroughs, Billions, and Big Bets

Biotech's Pulse: Gene-Editing's Leap, Cancer's New Fights, and What's Stirring the Industry

Navigating the Paradox: Why Genmab's Stock Dipped Despite Positive News for its Key Partnership

Biotech's Vanguard: Novo Nordisk, Omeros, and GSK Charting New Territories in Medical Innovation

Novo Nordisk Shifts Focus: Why the Cell Therapy Unit is Closing Its Doors

Nuvation Bio Soars: Pioneering Trial Success Ignites "Buy" Rating from Jefferies

Zevra Therapeutics Shares Skyrocket Amid Intense Takeover Speculation

Market Meltdowns & Mega-Deals: Unpacking Today's Biggest Stock Movers